For investors
Which claims in this pitch survive independent verification?
Venture, growth, and public-market investors underwriting healthcare-AI companies.
What we can answer for you
- Disclosed funding and institutional investor counts, sourced and dated.
- Deployment claims separated into independently corroborated versus vendor-asserted.
- Material events — partnerships, clearances, consolidation — on a dated timeline.
- Forecast questions with predeclared resolution rules and a published Brier score.
What we will not tell you
- This is not investment advice and carries no view on any security.
- We do not estimate revenue, ARR, or valuation. Where a vendor asserts a number, we label it as asserted.
How we weight evidence for this question
The Strategic lens — Capital position, momentum, platform trajectory. This reorders the same dimensions every audience sees. It never creates a separate score.
- 1market durability35%
- 2deployment traction25%
- 3evidence strength20%
- 4interoperability10%
- 5trust governance10%
Evidence state at this snapshot
3 of 39 products currently pass the documentary gate. 42 of 142 claims are independently confirmed. This is the same number for every audience — the framing changes, the evidence does not.
Other audiences